ARS Pharmaceuticals, Inc. (SPRY) Net Income

Annual Net Income:

$8.00M+$62.36M(+114.71%)
December 31, 2024

Summary

  • As of today, SPRY annual net profit is $8.00 million, with the most recent change of +$62.36 million (+114.71%) on December 31, 2024.
  • During the last 3 years, SPRY annual net income has risen by +$28.24 million (+139.51%).
  • SPRY annual net income is now at all-time high.

Performance

SPRY Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSPRYincome statement metrics

Quarterly Net Income:

-$51.15M-$6.27M(-13.97%)
September 30, 2025

Summary

  • As of today, SPRY quarterly net profit is -$51.15 million, with the most recent change of -$6.27 million (-13.97%) on September 30, 2025.
  • Over the past year, SPRY quarterly net income has dropped by -$32.02 million (-167.41%).
  • SPRY quarterly net income is now -202.44% below its all-time high of $49.93 million, reached on December 31, 2024.

Performance

SPRY Quarterly Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSPRYincome statement metrics

TTM Net Income:

-$80.04M-$32.02M(-66.69%)
September 30, 2025

Summary

  • As of today, SPRY TTM net profit is -$80.04 million, with the most recent change of -$32.02 million (-66.69%) on September 30, 2025.
  • Over the past year, SPRY TTM net income has dropped by -$30.94 million (-63.00%).
  • SPRY TTM net income is now -1100.75% below its all-time high of $8.00 million, reached on December 31, 2024.

Performance

SPRY TTM Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSPRYincome statement metrics

Net Income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

SPRY Net Income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+114.7%-167.4%-63.0%
3Y3 Years+139.5%-677.0%-83.1%
5Y5 Years+133.4%-290.9%-222.3%

SPRY Net Income Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+114.7%-202.4%at low-1100.8%at low
5Y5-Yearat high+114.7%-202.4%at low-1100.8%+10.6%
All-TimeAll-Timeat high+114.7%-202.4%at low-1100.8%+10.6%

SPRY Net Income History

DateAnnualQuarterlyTTM
Sep 2025
-
-$51.15M(-14.0%)
-$80.04M(-66.7%)
Jun 2025
-
-$44.88M(-32.2%)
-$48.02M(-206.8%)
Mar 2025
-
-$33.94M(-168.0%)
-$15.65M(-295.7%)
Dec 2024
$8.00M(+114.7%)
$49.93M(+361.1%)
$8.00M(+116.3%)
Sep 2024
-
-$19.13M(-52.8%)
-$49.10M(-9.5%)
Jun 2024
-
-$12.52M(-21.6%)
-$44.84M(+9.8%)
Mar 2024
-
-$10.29M(-43.6%)
-$49.70M(+8.6%)
Dec 2023
-$54.37M(-56.8%)
-$7.17M(+51.8%)
-$54.37M(-15.2%)
Sep 2023
-
-$14.87M(+14.4%)
-$47.20M(-21.3%)
Jun 2023
-
-$17.37M(-16.1%)
-$38.91M(-39.2%)
Mar 2023
-
-$14.96M(-127.3%)
-$27.96M(+36.0%)
Dec 2022
-$34.68M
-
-
DateAnnualQuarterlyTTM
Sep 2022
-
-$6.58M(-2.5%)
-$43.71M(+26.9%)
Jun 2022
-
-$6.42M(+11.4%)
-$59.78M(+23.2%)
Mar 2022
-
-$7.25M(+69.1%)
-$77.86M(+13.0%)
Dec 2021
-$20.24M(+38.6%)
-
-
Dec 2021
-
-$23.46M(-3.6%)
-$89.48M(-13.1%)
Sep 2021
-
-$22.66M(+7.5%)
-$79.10M(-40.1%)
Jun 2021
-
-$24.50M(-29.8%)
-$56.45M(-46.9%)
Mar 2021
-
-$18.87M(-44.2%)
-$38.42M(-54.7%)
Dec 2020
-$32.95M(-37.5%)
-$13.09M(-102.3%)
-$24.83M(-32.7%)
Jun 2020
-
-$6.47M(-22.5%)
-$18.72M(-52.8%)
Mar 2020
-
-$5.28M(+24.3%)
-$12.25M(-75.7%)
Dec 2019
-$23.97M(-36.3%)
-$6.97M
-$6.97M
Dec 2018
-$17.58M
-
-

FAQ

  • What is ARS Pharmaceuticals, Inc. annual net profit?
  • What is the all-time high annual net income for ARS Pharmaceuticals, Inc.?
  • What is ARS Pharmaceuticals, Inc. annual net income year-on-year change?
  • What is ARS Pharmaceuticals, Inc. quarterly net profit?
  • What is the all-time high quarterly net income for ARS Pharmaceuticals, Inc.?
  • What is ARS Pharmaceuticals, Inc. quarterly net income year-on-year change?
  • What is ARS Pharmaceuticals, Inc. TTM net profit?
  • What is the all-time high TTM net income for ARS Pharmaceuticals, Inc.?
  • What is ARS Pharmaceuticals, Inc. TTM net income year-on-year change?

What is ARS Pharmaceuticals, Inc. annual net profit?

The current annual net income of SPRY is $8.00M

What is the all-time high annual net income for ARS Pharmaceuticals, Inc.?

ARS Pharmaceuticals, Inc. all-time high annual net profit is $8.00M

What is ARS Pharmaceuticals, Inc. annual net income year-on-year change?

Over the past year, SPRY annual net profit has changed by +$62.36M (+114.71%)

What is ARS Pharmaceuticals, Inc. quarterly net profit?

The current quarterly net income of SPRY is -$51.15M

What is the all-time high quarterly net income for ARS Pharmaceuticals, Inc.?

ARS Pharmaceuticals, Inc. all-time high quarterly net profit is $49.93M

What is ARS Pharmaceuticals, Inc. quarterly net income year-on-year change?

Over the past year, SPRY quarterly net profit has changed by -$32.02M (-167.41%)

What is ARS Pharmaceuticals, Inc. TTM net profit?

The current TTM net income of SPRY is -$80.04M

What is the all-time high TTM net income for ARS Pharmaceuticals, Inc.?

ARS Pharmaceuticals, Inc. all-time high TTM net profit is $8.00M

What is ARS Pharmaceuticals, Inc. TTM net income year-on-year change?

Over the past year, SPRY TTM net profit has changed by -$30.94M (-63.00%)
On this page